BuybackMay 18, 2026, 10:36 AM
Novo Nordisk Repurchases DKK 4.17B Shares Under DKK 15B Program
AI Summary
Novo Nordisk provided an update on its ongoing share repurchase program, which aims to repurchase B shares for up to DKK 15 billion over a 12-month period starting February 4, 2026. A specific program initiated on May 6, 2026, targets repurchasing up to DKK 11.2 billion by February 1, 2027. As of May 13, 2026, the company has repurchased a total of 15,999,028 B shares since February 4, 2026, with a total transaction value of DKK 4,169,728,617. The company currently holds 33,184,329 B shares as treasury shares, equivalent to 0.7% of its share capital.
Key Highlights
- Novo Nordisk expects to repurchase B shares for up to DKK 15 billion during a 12-month period starting February 4, 2026.
- A specific program initiated May 6, 2026, targets repurchasing B shares up to DKK 11,200,000,010.45 by February 1, 2027.
- As of May 13, 2026, the company has repurchased 15,999,028 B shares since February 4, 2026.
- Total transaction value for repurchases since February 4, 2026, is DKK 4,169,728,617.
- The average share price for repurchases since February 4, 2026, is DKK 260.62 per B share.
- From May 6 to May 13, 2026, 1,239,849 B shares were repurchased for DKK 369,728,627.
- Novo Nordisk holds 33,184,329 B shares as treasury shares, representing 0.7% of its share capital.
Price Impact
More from NVO